320 related articles for article (PubMed ID: 25952784)
1. Present and future of personalized medicine in adult genitourinary tumors.
Ciccarese C; Santoni M; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M; Conti A; Tortora G; Cascinu S; Montironi R
Future Oncol; 2015; 11(9):1381-8. PubMed ID: 25952784
[TBL] [Abstract][Full Text] [Related]
2. Genitourinary cancers: molecular determinants for personalized therapies.
Mazzucchelli R; Gasparrini S; Galosi AB; Massari F; Raspollini MR; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
Urologia; 2016 Sep; 83(3):107-109. PubMed ID: 27338983
[TBL] [Abstract][Full Text] [Related]
3. Morphologic and molecular backgrounds for personalized management of genito-urinary cancers: an overview.
Montironi R; Santoni M; Lopez-Beltran A; Cheng L; Moch H; Scarpelli M
Curr Drug Targets; 2015; 16(2):96-102. PubMed ID: 25469883
[TBL] [Abstract][Full Text] [Related]
4. Genito-urinary genomics and emerging biomarkers for immunomodulatory cancer treatment.
Gevaert T; Montironi R; Lopez-Beltran A; Van Leenders G; Allory Y; De Ridder D; Claessens F; Kockx M; Akand M; Joniau S; Netto G; Libbrecht L
Semin Cancer Biol; 2018 Oct; 52(Pt 2):216-227. PubMed ID: 29032188
[TBL] [Abstract][Full Text] [Related]
5. Morphological and molecular backgrounds for personalized therapies in genitourinary cancers.
Montironi R; Scarpelli M; Santoni M; Lopez-Beltran A; Cheng L
Curr Drug Targets; 2015; 16(2):94-5. PubMed ID: 25668146
[No Abstract] [Full Text] [Related]
6. Immunotargeting and personalized therapies in genitourinary cancers.
Mazzucchelli R; Gasparrini S; Galosi AB; Massari F; Ciccarese C; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
Future Oncol; 2016 Aug; 12(16):1853-6. PubMed ID: 27113700
[No Abstract] [Full Text] [Related]
7. [Personalized urooncology based on molecular uropathology: what is the future?].
Dahl E; Haller F
Urologe A; 2013 Jul; 52(7):976-81. PubMed ID: 23831986
[TBL] [Abstract][Full Text] [Related]
8. Inside the 2015 ASCO Genitourinary Cancers Symposium.
Santoni M; Massari F; Iacovelli R; Ciccarese C; Verri E; Burattini L; Montironi R; Nolè F; Tortora G; Cascinu S
Future Oncol; 2015; 11(13):1859-62. PubMed ID: 26161923
[TBL] [Abstract][Full Text] [Related]
9. Toward personalized management in bladder cancer: the promise of novel molecular taxonomy.
Eich ML; Dyrskjøt L; Netto GJ
Virchows Arch; 2017 Aug; 471(2):271-280. PubMed ID: 28429075
[TBL] [Abstract][Full Text] [Related]
10. Pediatric genitourinary tumors.
Castellino SM; McLean TW
Curr Opin Oncol; 2007 May; 19(3):248-53. PubMed ID: 17414644
[TBL] [Abstract][Full Text] [Related]
11. A decision support framework for genomically informed investigational cancer therapy.
Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335
[TBL] [Abstract][Full Text] [Related]
12. Evolving Role of Genomics in Genitourinary Neoplasms.
Devitt ME; Dreicer R
Acta Med Acad; 2019 Apr; 48(1):68-77. PubMed ID: 31264434
[TBL] [Abstract][Full Text] [Related]
13. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
Kamel HFM; Al-Amodi HSAB
Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
[TBL] [Abstract][Full Text] [Related]
14. Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice.
Bianconi M; Santoni M; Massari F; Faloppi L; Del Prete M; Giampieri R; Ciccarese C; Modena A; Tortora G; Scartozzi M; Cascinu S
Future Oncol; 2014 Nov; 10(14):2103-6. PubMed ID: 25471023
[TBL] [Abstract][Full Text] [Related]
15. Applications of Genomic Sequencing in Pediatric CNS Tumors.
Bavle AA; Lin FY; Parsons DW
Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
[TBL] [Abstract][Full Text] [Related]
16. Successes and limitations of targeted cancer therapy in breast cancer.
Curigliano G; Criscitiello C
Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
[TBL] [Abstract][Full Text] [Related]
17. Individualized management of advanced bladder cancer: Where do we stand?
Burgess EF
Urol Oncol; 2015 Apr; 33(4):187-95. PubMed ID: 24332641
[TBL] [Abstract][Full Text] [Related]
18. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
19. Pediatric genitourinary tumors.
Castellino SM; Martinez-Borges AR; McLean TW
Curr Opin Oncol; 2009 May; 21(3):278-83. PubMed ID: 19295433
[TBL] [Abstract][Full Text] [Related]
20. An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine.
Nasser S; Kurdolgu AA; Izatt T; Aldrich J; Russell ML; Christoforides A; Tembe W; Keifer JA; Corneveaux JJ; Byron SA; Forman KM; Zuccaro C; Keats JJ; Lorusso PM; Carpten JD; Trent JM; Craig DW
Pac Symp Biocomput; 2015; ():56-67. PubMed ID: 25592568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]